Literature DB >> 15096630

Backbone dynamics of complement control protein (CCP) modules reveals mobility in binding surfaces.

Joanne M O'Leary1, Krystyna Bromek, Gordon M Black, Stanislava Uhrinova, Christian Schmitz, Xuefeng Wang, Malgorzata Krych, John P Atkinson, Dusan Uhrin, Paul N Barlow.   

Abstract

The regulators of complement activation (RCA) are critical to health and disease because their role is to ensure that a complement-mediated immune response to infection is proportionate and targeted. Each protein contains an uninterrupted array of from four to 30 examples of the very widely occurring complement control protein (CCP, or sushi) module. The CCP modules mediate specific protein-protein and protein-carbohydrate interactions that are key to the biological function of the RCA and, paradoxically, provide binding sites for numerous pathogens. Although structural and mutagenesis studies of CCP modules have addressed some aspects of molecular recognition, there have been no studies of the role of molecular dynamics in the interaction of CCP modules with their binding partners. NMR has now been used in the first full characterization of the backbone dynamics of CCP modules. The dynamics of two individual modules-the 16th of the 30 modules of complement receptor type 1 (CD35), and the N-terminal module of membrane cofactor protein (CD46)-as well as their solution structures, are compared. Although both examples share broadly similar three-dimensional structures, many structurally equivalent residues exhibit different amplitudes and timescales of local backbone motion. In each case, however, regions of the module-surface implicated by mutagenesis as sites of interactions with other proteins include several mobile residues. This observation suggests further experiments to explore binding mechanisms and identify new binding sites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096630      PMCID: PMC2286753          DOI: 10.1110/ps.03582704

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  46 in total

Review 1.  Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster.

Authors:  M K Liszewski; T W Post; J P Atkinson
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

2.  Structure-function relationships of the complement components.

Authors:  K B Reid; A J Day
Journal:  Immunol Today       Date:  1989-06

3.  Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis.

Authors:  M Krych; L Clemenza; D Howdeshell; R Hauhart; D Hourcade; J P Atkinson
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

4.  The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor.

Authors:  A Maisner; J Alvarez; M K Liszewski; D J Atkinson; J P Atkinson; G Herrler
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Solution structure of a pair of complement modules by nuclear magnetic resonance.

Authors:  P N Barlow; A Steinkasserer; D G Norman; B Kieffer; A P Wiles; R B Sim; I D Campbell
Journal:  J Mol Biol       Date:  1993-07-05       Impact factor: 5.469

6.  Measurement of HN-H alpha J couplings in calcium-free calmodulin using new 2D and 3D water-flip-back methods.

Authors:  H Kuboniwa; S Grzesiek; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1994-11       Impact factor: 2.835

7.  Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease.

Authors:  L E Kay; D A Torchia; A Bax
Journal:  Biochemistry       Date:  1989-11-14       Impact factor: 3.162

8.  Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.

Authors:  M Krych; D Hourcade; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

9.  Backbone dynamics of Escherichia coli ribonuclease HI: correlations with structure and function in an active enzyme.

Authors:  A M Mandel; M Akke; A G Palmer
Journal:  J Mol Biol       Date:  1995-02-10       Impact factor: 5.469

10.  Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.

Authors:  H F Weisman; T Bartow; M K Leppo; H C Marsh; G R Carson; M F Concino; M P Boyle; K H Roux; M L Weisfeldt; D T Fearon
Journal:  Science       Date:  1990-07-13       Impact factor: 47.728

View more
  11 in total

1.  Localization of regions in CD46 that interact with adenovirus.

Authors:  Anuj Gaggar; Dmitry M Shayakhmetov; M Kathryn Liszewski; John P Atkinson; André Lieber
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand.

Authors:  Christy Rani R Grace; Marilyn H Perrin; Jozsef Gulyas; Michael R Digruccio; Jeffrey P Cantle; Jean E Rivier; Wylie W Vale; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-12       Impact factor: 11.205

3.  Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics.

Authors:  Li Zhang; Dimitrios Morikis
Journal:  Biophys J       Date:  2006-02-10       Impact factor: 4.033

4.  SRPX2 Enhances the Epithelial-Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Cells.

Authors:  Haitao Tang; Jiaxin Zhao; Liangyu Zhang; Jiang Zhao; Yongzhi Zhuang; Peng Liang
Journal:  Cell Mol Neurobiol       Date:  2015-12-07       Impact factor: 5.046

5.  SRPX2 is a novel chondroitin sulfate proteoglycan that is overexpressed in gastrointestinal cancer.

Authors:  Kaoru Tanaka; Tokuzo Arao; Daisuke Tamura; Keiichi Aomatsu; Kazuyuki Furuta; Kazuko Matsumoto; Hiroyasu Kaneda; Kanae Kudo; Yoshihiko Fujita; Hideharu Kimura; Kazuyoshi Yanagihara; Yasuhide Yamada; Isamu Okamoto; Kazuhiko Nakagawa; Kazuto Nishio
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

6.  Identification, characterization and antigenicity of the Plasmodium vivax rhoptry neck protein 1 (PvRON1).

Authors:  Darwin A Moreno-Perez; Marjorie Montenegro; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  Malar J       Date:  2011-10-24       Impact factor: 2.979

7.  Comparative analyses of glycerotoxin expression unveil a novel structural organization of the bloodworm venom system.

Authors:  Sandy Richter; Conrad Helm; Frederic A Meunier; Lars Hering; Lahcen I Campbell; Stephan H Drukewitz; Eivind A B Undheim; Ronald A Jenner; Giampietro Schiavo; Christoph Bleidorn
Journal:  BMC Evol Biol       Date:  2017-03-04       Impact factor: 3.260

8.  High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer.

Authors:  Meng Zhang; Xiaoli Li; Zhirui Fan; Jing Zhao; Shuzheng Liu; Mingzhi Zhang; Huixiang Li; Mariusz Adam Goscinski; Huijie Fan; Zhenhe Suo
Journal:  Onco Targets Ther       Date:  2018-05-28       Impact factor: 4.147

9.  Cardiolipin interacts with beta-2-glycoprotein I and forms an open conformation-Mechanisms analyzed using hydrogen/deuterium exchange.

Authors:  Kuo-Tung Tang; Ting-Yuan Wu; Hsin-Hua Chen; Chi-Chien Lin; Yuan-Hao Howard Hsu
Journal:  Protein Sci       Date:  2021-03-15       Impact factor: 6.725

10.  The Sez6 Family Inhibits Complement by Facilitating Factor I Cleavage of C3b and Accelerating the Decay of C3 Convertases.

Authors:  Wen Q Qiu; Shaopeiwen Luo; Stefanie A Ma; Priyanka Saminathan; Herman Li; Jenny M Gunnersen; Harris A Gelbard; Jennetta W Hammond
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.